Llwytho...
Targeting EZH2 for Cancer Therapy: Progress and Perspective
Enhancer of Zeste Homolog 2 (EZH2) is the core component of the polycomb repressive complex 2 (PRC2), possessing the enzymatic activity in generating di/tri-methylated lysine 27 in histone H3. EZH2 has important roles during early development, and its dysregulation is heavily linked to oncogenesis i...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Curr Protein Pept Sci |
|---|---|
| Prif Awduron: | , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
Bentham Science Publishers
2015
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4997953/ https://ncbi.nlm.nih.gov/pubmed/25854924 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1389203716666150409100233 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|